2023-03-23 11:39:32 ET
With a market size of 20 billion, there is plenty of long-term value for smoking %CessationProducts . And this company just received patent approval in another country for its smoking cessation product.
Consumer wellness company %CVSciences (OTCQB: ) specializes in %HempExtracts and other proven, science-backed, natural ingredients and products. In its press release today, the company announced that it received its formal Certificate of Grant from the %JapanPatentOffice for its patent application 7216697.
The patent covers methods of treating smokeless tobacco addiction by administering pharmaceutical formulations containing %CBD and nicotine. The firm has also filed corresponding patent applications that provide similar patent protection in additional key markets, with patents already granted in the United States, Canada, Australia, Germany, Great Britain, France, Spain, Netherlands and Italy.
Shares were trading up in mid-morning trade.